FeesSafety
Pluang+

Iovance grants stock options to 22 new employees under Nasdaq inducement plan.

Company Fundamentals
21 Nov 2026, 00:15 WIB
GlobeNewsWire
View Source
Neutral
Iovance grants stock options to 22 new employees under Nasdaq inducement plan.

Iovance Biotherapeutics approved inducement stock options for 175,840 shares to 22 new non-executive employees on November 19, 2026. These options have an exercise price of $7.31 and vest over three years, rewarding employee retention. The grants are part of Iovance's 2021 Inducement Plan, complying with Nasdaq rules. This move supports Iovance's growth as a leader in tumor infiltrating lymphocyte therapies for cancer treatment.

Iovance Biotherapeutics trades at USD 7.07 on Pluang as of Nov 21, 2026 05:11 WIB, down 3.28% in one day. The stock's market cap stands at $3.38 billion with a 52-week high of $14.86. Trading volume was 8,533,623 shares, reflecting active investor interest around the announcement date.

More News (IOVA)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App